American Century Companies
BHVN

American Century Companies’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

American Century Companies’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-287,812
Closed -$43.5M – 2650
2022
Q3 		$43.5M Buy
287,812
+96,781
+51% +$14.3M 0.04% 420
2022
Q2 		$27.8M Sell
191,031
-493,803
-72% -$63.1M 0.02% 574
2022
Q1 		$81.2M Buy
684,834
+494,275
+259% +$61.6M 0.06% 340
2021
Q4 		$26.3M Sell
190,559
-88,217
-32% -$11.2M 0.02% 630
2021
Q3 		$38.7M Buy
278,776
+91,051
+49% +$11.4M 0.03% 517
2021
Q2 		$18.2M Buy
187,725
+1,696
+0.9% +$138K 0.01% 689
2021
Q1 		$12.7M Sell
186,029
-2,629
-1% -$213K 0.01% 739
2020
Q4 		$16.2M Buy
188,658
+10,591
+6% +$897K 0.01% 666
2020
Q3 		$11.6M Buy
178,067
+27,811
+19% +$1.82M 0.01% 680
2020
Q2 		$11M Buy
150,256
+74,466
+98% +$3.96M 0.01% 652
2020
Q1 		$2.58M Buy
+75,790
New +$3.47M ﹤0.01% 816
2018
Q1 		– Sell
-57,216
Closed -$1.54M – 1405
2017
Q4 		$1.54M Buy
57,216
+20,444
+56% +$563K ﹤0.01% 1046
2017
Q3 		$1.38M Sell
36,772
-19,618
-35% -$595K ﹤0.01% 1096
2017
Q2 		$1.41M Buy
+56,390
New +$1.3M ﹤0.01% 1089

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

American Century Companies's BHVN Position: Q4 2022 in Review

American Century Companies sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 287,812 shares — an estimated $43.5M sold.

American Century Companies first reported a position in BHVN in Q2 2017 and held it in 14 quarters. The position peaked at $81.2M in Q1 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • American Century Companies reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • American Century Companies sold 287,812 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $43.5M.
  • American Century Companies first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 14 quarters.
  • American Century Companies's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $81.2M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on American Century Companies's 13F filing for Q4 2022, filed 13 Feb 2023.